Neoprobe

Provider of gamma detection devices and radiopharmaceuticals for cancer

placeCincinnati, Ohio, United States calendar_todayFounded 1996 language neoprobe.com

Innovation

4 patent families (2 granted) — focus: Physics & computing, Human necessities, Chemistry & metallurgy; filing pace dormant. Cited 122 times.

YearFilings
20122
20141
20161
20171
20181

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital125%
Private equity125%
Bank & private debt125%
Other / undisclosed125%
Coming soon